The resolution proposes an interim study to investigate the role of pharmacy benefit managers (PBMs) in Nebraska's health insurance sector, particularly focusing on their influence on prescription drug prices and the transparency of their practices. As prescription costs continue to rise, creating financial strain for residents and businesses, the study aims to evaluate the contractual relationships between PBMs, health insurance plans, and pharmacies, as well as the reimbursement models and formulary management practices employed by PBMs. The resolution highlights the need to understand how these factors affect patient access to affordable medications and the operations of independent pharmacies.

The Banking, Commerce and Insurance Committee of the Nebraska Legislature is tasked with conducting this interim study. Upon completion, the committee is required to report its findings and recommendations to the Legislative Council or the Legislature, with the goal of identifying potential legislative or regulatory solutions to address the concerns surrounding PBM practices and their impact on prescription drug affordability and accessibility for Nebraskans.